Allocation and Catalytic Investment Access to

Transcript:Allocation and Catalytic Investment Access to:
Allocation and Catalytic Investment Access to Funding 1 Contents 1 Allocation Methodology Catalytic Investments 1 2 Overview 2 Global Fund has adopted a refined allocation methodology to Deliver the aims of 2017-2022 Strategy: Investing to End Epidemics Increase impact of programs to prevent, treat and care for people affected by HIV, TB and malaria, and build resilient and sustainable systems for health The refined methodology does this by Driving increased proportion of funding to higher burden, lower income countries Specifically accounting for epidemics among key and vulnerable populations, the threat of MDR-TB, and for malaria elimination efforts Providing sustainable and paced reductions where funding is decreasing Refinements guided by Key Lessons Learned from 2014-2016 3 Adopting allocation-based funding model enabled Global Fund to actively shape portfolio and align funding to achieve impact in line with Global Partner plans Lessons learned indicated scope for refinement to improve impact: Limited ability to scale-up in higher burden, lower income countries Country Bands limited flexibility to address critical funding shortfalls Needs of key & vulnerable populations, threat of MDR-TB and malaria elimination insufficiently addressed Incentive funding used to fill gaps rather than catalyze toward strategic aims Multiple multi-country approaches, not always focused on key global regional barriers to ending epidemics Calculation of Country Allocations 4 Disease Burden Country Economic Capacity x Formula-derived Allocation Allocation Formula Maximizes impact in line with disease burden & country economic capacity All but $800m for robust & predictable allocations Scale-up for high burden, below-formula components Movement of limited funds & flexibility to balance paced-reductions Increased emphasis on MDR in TB allocations, as recommended by Technical Partners Initial Calculated Amount $800m moved for scale-up, impact, paced reductions Max/ min shares, external financing adjustments Transparent and accountable process, carried out under Strategy Committee oversight Qualitative adjustment process 2017-2019 Aims Refine allocations for epidemiological contexts not addressed through formula Account for country-specific contextual considerations to maximize the impact of Global Fund resources in line with the 2017-2022 Strategy Two-stage Process (does not change global disease split) Stage 1: Refining for epidemiological contexts Stage 2: Single, holistic adjustment Potential for impact & potential absorption Populations disproportionally affected by HIV Low Endemicity Malaria Supported by contextual considerations incl. coverage gaps, risk, domestic/ external financing trends, program efficiencies, buying power, cost of continuing essential programming TB adjustment to be pursued for next allocation period Outcomes of Allocation Methodology 2017-2019 6 16% 2,000 1,000 0 14%